French drugmaker Sanofi's Monday confirmation that it plans to sell a controlling stake in its over-the-counter unit to a US ...

Sanofi announced on Monday that it had entered into exclusive negotiations with US investment fund CD&R to sell it a majority ...

PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

Sanofi entered into exclusive talks to sell its consumer-healthcare business Opella to Clayton Dubilier & Rice in a deal that ...

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health ...

Sanofi said on Monday (Oct 21) it had entered exclusive talks for the sale of a 50 per cent controlling stake in its consumer ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...

PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year.

PAI Partners raises offer for Sanofi's consumer health unit, Opella, by €200 million and aims to keep key operations in ...

The planned sale of France's best-selling medical drug to US investors has caused the government a splitting headache after ...